Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer

被引：5
|
作者：
Elham Fakhrejahani
Akiko Miyamoto
Nobuhiko Tanigawa
机构：
[1] Osaka Medical College,Department of General and Gastroenterological Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷 / 3期
关键词：
D O I：
10.1007/s00280-007-0501-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：447 / 447
相关论文
共 50 条
  • [31] Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR
    Fujiwara, H
    Terashima, M
    Irinoda, T
    Takagane, A
    Abe, K
    Kashiwaba, M
    Oyama, K
    Takahashi, M
    Maesawa, C
    Saito, K
    Takechi, T
    Fukushima, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (12): : 1342 - 1350
  • [32] Correlation between augmentative effects of leucovorin on 5-fluorouracil and thymidylate synthase inhibition
    Yamada Y.
    Sakata Y.
    Tsushima K.
    Satoh T.
    International Journal of Clinical Oncology, 1997, 2 (1) : 10 - 14
  • [33] The relation of thymidylate synthase activity and the antitumor effect of 5-fluorouracil
    Matsuoka, K
    Tsukuda, K
    Ota, T
    Okita, A
    Watanabe, K
    Suzuki, E
    Murakami, M
    Shimizu, N
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 435 - 435
  • [34] Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma
    R. Fujii
    A. Seshimo
    S. Kameoka
    International Journal of Clinical Oncology, 2003, 8 (2) : 0072 - 0078
  • [35] Clinical implications of thymidylate synthetase mRNA level and dihydropyrimidine dehydrogenase mRNA level in oral cancer
    Nakamura, A
    Iguchi, H
    Kusuki, M
    Hachiya, K
    Yamane, H
    ORAL ONCOLOGY, 2005, 1 (01) : 171 - 171
  • [36] Intratumoral dihydropyrimidine dehydrogenase (DPD) mRNA level and thymidylate synthase (TS) mRNA induction by 5-FU treatment in colorectal cancer patients
    Blömeke, B
    Tanaka, M
    Onda, M
    Tanaka, N
    Hurukawa, K
    Takasaki, H
    Yoshimura, K
    Suzuki, H
    Naito, Z
    Merk, HF
    Kato, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R144 - R144
  • [37] Impact of dihydropyrimidine dehydrogenase on 5-fluorouracil treatment in cancer patients
    Schneider, HB
    Becker, H
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2003, 8 (05) : 226 - 228
  • [38] SCHEDULE-DEPENDENT INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL IN GASTRIC-CANCER
    TSUJINAKA, T
    KIDO, Y
    SHIOZAKI, H
    IIJIMA, S
    HOMMA, T
    SAKAUE, M
    MORI, T
    CANCER, 1992, 70 (12) : 2761 - 2765
  • [39] Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients
    Tsujitani, S
    Konishi, I
    Suzuki, K
    Oka, S
    Gomyo, Y
    Matsumoto, S
    Hirooka, Y
    Kaibara, N
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2000, 19 (02) : 189 - 195
  • [40] Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma: Relationship between histological parameters and chemosensitivity to 5-fluorouracil
    Hirano, Y
    Takayama, T
    Kageyama, S
    Ushiyama, T
    Suzuki, K
    Fujita, K
    EUROPEAN UROLOGY, 2003, 43 (01) : 45 - 51
12345